Lysosomal Therapeutics

6 Decision Makers · 7 Verified Contacts

📍 Cambridge, MABiotechnology🗓 Est. 2011👥 Under 10 employees

About Lysosomal Therapeutics

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

Leadership & Decision Makers

Contact details of 6 Lysosomal Therapeutics decision makers

Edmund Sybertz

Founder

Joseph Mazzulli

Scientific Founder

Henri Termeer

Founder

Dimitri Krainc

Principal Founding Scientist

Kees Been

Founder

Peter Wirth

Founder

Team & Specialists

Contact details of 1 Lysosomal Therapeutics team members

Mark Carthy

Investor

General Emails

General company emails, e.g. customer support lines

    info@lysosomaltx.com

    General Inquiries

Similar Companies like Lysosomal Therapeutics

Cullinan Oncology

cullinanoncology.com
Pharmaceuticals · Cambridge, MA · Est. 2017 · 11–50 employees

HQ: Cambridge, MA

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

nference

nference.com
Biotechnology · Cambridge, MA · Est. 2013 · 251–500 employees

HQ: Cambridge, MA

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Explore similar firms in the Biotechnology sector

Company Info

617-913-0166

Cambridge, MA

Specialization: Therapeutics,
Legal Name: LYSOSOMAL THERAPEUTICS, INC.
Business Type: Private
Employees: 1-10
Rounds: Series A
Founded Date: 2011
Number of Exits: 3
Company Type: For Profit
Operating Status: Active
Last Funding Type: Series A
Phone Number: 617-913-0166
Last Investment Activity: Oct 8, 2020
Investments Activity: Oct 8, 2020 Sep 18, 2019 Aug 22, 2019

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.